{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:07:27Z","timestamp":1748837247119},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating lytic brain infection caused by the John Cunningham virus (JCV). JCV manifests primarily in patients with innate immunodeficiency or taking immunomodulatory medications. In this case study, we report a PML patient with comorbid mediastinal teratoma and mild lymphopenia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 73-year-old female presented with a 3-month history of progressive hemiplegia, hemianopsia, and cognitive impairment. She was diagnosed as PML by cerebrospinal fluid metagenomics sequencing and brain biopsy. Extensive immunological tests did not reveal an apparent immunodeficiency, but further work-up revealed that the PML was most likely the first presentation of mediastinal teratoma and the mild lymphopenia. Mirtazapine and immunoglobulin were started, the patient\u2019s condition was relatively stable and approved to be discharged from hospital. But unfortunately, she died of the lung infection 10\u2009months after first presentation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case confirms that mediastinal teratoma may induce the lymphopenia and trigger PML, delayed or incorrect diagnosis may worsen the course of the disease and result in poor prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02563-y","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:03:10Z","timestamp":1643284990000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progressive multifocal leukoencephalopathy in a patient with mediastinal teratoma: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueshan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meina","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"2563_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CD, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25:471\u2013506.","journal-title":"Clin Microbiol Rev"},{"key":"2563_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaneurol.2018.0094","volume":"75","author":"MT Wijburg","year":"2018","unstructured":"Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, et al. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume with JC virus polymerase chain reaction results in cerebrospinal fluid of Natalizumab-treated patients with multiple sclerosis. JAMA Neurol. 2018;75:827\u201333.","journal-title":"JAMA Neurol"},{"key":"2563_CR3","first-page":"137","volume":"20","author":"S Beltrami","year":"2014","unstructured":"Beltrami S, Gordon J. Immune surveillance and response to JC virus infection and PML. J Neuro-Oncol. 2014;20:137\u201349.","journal-title":"J Neuro-Oncol"},{"key":"2563_CR4","doi-asserted-by":"publisher","first-page":"577721","DOI":"10.1016\/j.jneuroim.2021.577721","volume":"360","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Kataria S, Srivastava S, et al. Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimmunol. 2021;360:577721.","journal-title":"J Neuroimmunol"},{"key":"2563_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s40264-016-0461-6","volume":"39","author":"E D'Amico","year":"2016","unstructured":"D'Amico E, Zanghi A, Leone C, Tumani H, Patti F. Treatment-related progressive multifocal leukoencephalopathy in multiple sclerosis: a comprehensive review of current evidence and future needs. Drug Saf. 2016;39:1163\u201374.","journal-title":"Drug Saf"},{"key":"2563_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/jnnp.2009.190652","volume":"82","author":"TE Gofton","year":"2011","unstructured":"Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2011;82:452\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2563_CR7","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1212\/WNL.0b013e318259e210","volume":"78","author":"JN Chabwine","year":"2012","unstructured":"Chabwine JN, Lhermitte B, Da Silva MO, Buss G, Maeder P, Du Pasquier RA. Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia. Neurology. 2012;78:2000\u20132.","journal-title":"Neurology"},{"key":"2563_CR8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/ccr3.1816","volume":"6","author":"I Gamperl","year":"2018","unstructured":"Gamperl I, Enzinger C, Pichler A, Feichtinger M, Schlager T, Fertl E. Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature. Clin Case Rep. 2018;6:2121\u20135.","journal-title":"Clin Case Rep"},{"key":"2563_CR9","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious disease section. Neurology. 2013;80:1430\u20138.","journal-title":"Neurology"},{"key":"2563_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2020.01745","volume":"11","author":"S Kinsella","year":"2020","unstructured":"Kinsella S, Dudakov JA. When the damage is done: injury and repair in Thymus function. Front Immunol. 2020;11:1745.","journal-title":"Front Immunol"},{"key":"2563_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.smim.2007.10.001","volume":"19","author":"N Legrand","year":"2007","unstructured":"Legrand N, Dontje W, van Lent AU, Spits H, Blom B. Human thymus regeneration and T cell reconstitution. Semin Immunol. 2007;19:280\u20138.","journal-title":"Semin Immunol"},{"key":"2563_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nri3028","volume":"11","author":"PJ Fink","year":"2011","unstructured":"Fink PJ, Hendricks DW. Post-thymic maturation: young T cells assert their individuality. Nat Rev Immunol. 2011;11:544\u20139.","journal-title":"Nat Rev Immunol"},{"key":"2563_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.smim.2012.04.002","volume":"24","author":"VD Dixit","year":"2012","unstructured":"Dixit VD. Impact of immune-metabolic interactions on age-related thymic demise and T cell senescence. Semin Immunol. 2012;24:321\u201330.","journal-title":"Semin Immunol"},{"key":"2563_CR14","doi-asserted-by":"crossref","unstructured":"Toorop AA, van Lierop ZYG, Strijbis EEM, et al. Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Neurol Neuroimmunol Neuroinflamm. 2020;13;8:e904.","DOI":"10.1212\/NXI.0000000000000904"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02563-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:03:19Z","timestamp":1643284999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02563-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02563-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient\u2019s next of kin to publish this case, and approval for this study was provided by the research ethics committee of the xuanwu hospital of capital medical university.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}